A novel phosphoglucomutase‐deficient mouse model reveals aberrant glycosylation and early embryonic lethality
- 11 May 2019
- journal article
- research article
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 42 (5) , 998-1007
Abstract
Patients with phosphoglucomutase (PGM1) deficiency, a congenital disorder of glycosylation (CDG) suffer from multiple disease phenotypes. Midline cleft defects are present at birth. Overtime, additional clinical phenotypes, which include severe hypoglycemia, hepatopathy, growth retardation, hormonal deficiencies, hemostatic anomalies, frequently lethal, early‐onset of dilated cardiomyopathy and myopathy emerge, reflecting the central roles of the enzyme in (glycogen) metabolism and glycosylation. To delineate the pathophysiology of the tissue‐specific disease phenotypes, we constructed a constitutive Pgm2 (mouse ortholog of human PGM1)‐knockout (KO) mouse model using CRISPR‐Cas9 technology. After multiple crosses between heterozygous parents, we were unable to identify homozygous life births in 78 newborn pups (P = 1.59897E‐06), suggesting an embryonic lethality phenotype in the homozygotes. Ultrasound studies of the course of pregnancy confirmed Pgm2‐deficient pups succumb before E9.5. Oral galactose supplementation (9 mg/mL drinking water) did not rescue the lethality. Biochemical studies of tissues and skin fibroblasts harvested from heterozygous animals confirmed reduced Pgm2 enzyme activity and abundance, but no change in glycogen content. However, glycomics analyses in serum revealed an abnormal glycosylation pattern in the Pgm2+/− animals, similar to that seen in PGM1‐CDG.Keywords
Funding Information
- National Center for Advancing Translational Sciences (FP00096621)
- National Institutes of Health (S10 RR027506‐01)
This publication has 27 references indexed in Scilit:
- Gene identification in the congenital disorders of glycosylation type I by whole-exome sequencingHuman Molecular Genetics, 2012
- Successful prenatal mannose treatment for congenital disorder of glycosylation-Ia in miceNature Medicine, 2011
- Congenital disorders of glycosylation (CDG): it's (nearly) all in it!Journal of Inherited Metabolic Disease, 2011
- Muscle Glycogenosis Due to Phosphoglucomutase 1 DeficiencyNew England Journal of Medicine, 2009
- Microarray analysis of Foxa2 mutant mouse embryos reveals novel gene expression and inductive roles for the gastrula organizer and its derivativesBMC Genomics, 2008
- Agm1/Pgm3-Mediated Sugar Nucleotide Synthesis Is Essential for Hematopoiesis and DevelopmentMolecular and Cellular Biology, 2007
- Targeted Disruption of the Mouse Phosphomannomutase 2 Gene Causes Early Embryonic LethalityMolecular and Cellular Biology, 2006
- Ablation of Mouse Phosphomannose Isomerase (Mpi) Causes Mannose 6-Phosphate Accumulation, Toxicity, and Embryonic LethalityJournal of Biological Chemistry, 2006
- Linkage of the Dao-1 gene for D-amino-acid oxidase to the pgm-1 gene for phosphoglucomutase-1 on the mouse chromosome 5.The Japanese Journal of Genetics, 1989
- Phosphoglucomutase electrophoretic variants in the mouseBiochemical Genetics, 1969